Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Uno studio su MK-1084 più Pembrolizumab (MK-3475) in partecipanti con carcinoma polmonare non a piccole cellule (NSCLC) metastatico con mutazione KRAS G12C con punteggio di proporzione del tumore (TPS) ≥ 50% del ligando di morte cellulare programmata 1 (PD-L1) (MK-1084-004)

11 novembre 2026 aggiornato da: Merck Sharp & Dohme LLC

Uno studio multicentrico di fase 3, randomizzato, in doppio cieco, su MK-1084 in combinazione con pembrolizumab rispetto a pembrolizumab più placebo come trattamento di prima linea di partecipanti con NSCLC metastatico con mutante KRAS G12C con PD-L1 TPS ≥50%

This is a study evaluating the efficacy and safety of calderasib with pembrolizumab as first-line treatment in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) with identified Kirsten rat sarcoma viral oncogene homolog G12C (KRAS G12C) mutation and programmed cell death ligand 1 (PD-L1) tumor proportion score (TPS) ≥50%. There is one primary study hypothesis:

Combination of calderasib and pembrolizumab is superior to placebo plus pembrolizumab with respect to progression free survival (PFS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) by blinded independent central review (BICR).

Panoramica dello studio

Descrizione dettagliata

Per Protocol Amendment 04, overall survival (OS) was moved to be a secondary outcome measure. Additionally, no new participants will be offered Second Course treatment for pembrolizumab.

Tipo di studio

Interventistico

Iscrizione (Stimato)

348

Fase

  • Fase 3

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Buenos Aires
      • Berazategui, Buenos Aires, Argentina, B1884BBF
        • Reclutamento
        • Centro de Oncología e Investigación de Buenos Aires ( Site 0308)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +541142262013
      • CABA, Buenos Aires, Argentina, C1019ABS
        • Completato
        • AUSTRAL MEDICAL CENTER ( Site 0302)
      • CABA, Buenos Aires, Argentina, C1426AGE
        • Reclutamento
        • Centro Oncologico Korben ( Site 0304)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 1157507952
      • Mar del Plata, Buenos Aires, Argentina, B7600FZO
        • Reclutamento
        • Instituto de Investigaciones Clínicas Mar del Plata ( Site 0300)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 02234963224
    • Río Negro Province
      • Viedma, Río Negro Province, Argentina, R8500ACE
        • Reclutamento
        • Clinica Viedma S. A ( Site 0307)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +54 2920 42-8700
    • Santa Fe Province
      • Rosario, Santa Fe Province, Argentina, S2000DEJ
        • Reclutamento
        • Fundacion Estudios Clinicos ( Site 0306)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +543412221472
      • Rosario, Santa Fe Province, Argentina, S2000DSV
        • Reclutamento
        • Sanatorio Parque ( Site 0301)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +54341420-0222
    • New South Wales
      • Camperdown, New South Wales, Australia, 2050
        • Reclutamento
        • Chris O'Brien Lifehouse ( Site 3000)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +61285140140
    • Queensland
      • Urraween, Queensland, Australia, 4655
        • Reclutamento
        • Cancer Care Service Hervey Bay ( Site 3003)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +610743256110
    • Victoria
      • Frankston, Victoria, Australia, 3199
        • Reclutamento
        • Frankston Hospital ( Site 3002)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +61397847777
    • Western Australia
      • Nedlands, Western Australia, Australia, 6009
        • Reclutamento
        • One Clinical Research ( Site 3001)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +61862799466
      • Vienna, Austria, 1210
        • Reclutamento
        • Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 2400)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 0043 1 27700 72212
    • Styria
      • Graz, Styria, Austria, 8036
        • Reclutamento
        • Medizinische Universität Graz-Klinische Abteilung für Pulmonologie ( Site 2401)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 004331638512183
      • Rio de Janeiro, Brasile, 22775-001
        • Reclutamento
        • Americas ( Site 0431)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +552133852088
      • Rio de Janeiro, Brasile, 20230-130
        • Reclutamento
        • Instituto Nacional de Câncer - INCA ( Site 0446)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +552132076564
    • Minas Gerais
      • Belo Horizonte, Minas Gerais, Brasile, 30380-472
        • Reclutamento
        • Hospital Mario Penna ( Site 0436)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +553132999543
    • Pernambuco
      • Recife, Pernambuco, Brasile, 50040-000
        • Reclutamento
        • Hospital de Câncer de Recife ( Site 0447)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +558132178084
    • Piauí
      • Teresina, Piauí, Brasile, 64049-200
        • Completato
        • Oncoclínica Oncologistas Associados ( Site 0441)
    • Rio Grande do Norte
      • Natal, Rio Grande do Norte, Brasile, 59062-000
        • Reclutamento
        • Liga Norte Riograndense Contra o Câncer ( Site 0439)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +558440095595
    • Rio Grande do Sul
      • Ijuí, Rio Grande do Sul, Brasile, 98700 000
        • Reclutamento
        • Hospital de Caridade de Ijuí ( Site 0438)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +5555991221138
      • Passo Fundo, Rio Grande do Sul, Brasile, 99010-260
        • Reclutamento
        • Hospital de Clínicas de Passo Fundo ( Site 0442)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +5554981271411
      • Porto Alegre, Rio Grande do Sul, Brasile, 90050-170
        • Reclutamento
        • Irmandade da Santa Casa de Misericórdia de Porto Alegre-Centro Multidisciplinar de Pesquisa Clínica ( Site 0435)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +555132148143
    • São Paulo
      • Barretos, São Paulo, Brasile, 14784-400
        • Reclutamento
        • Fundação Pio XII - Hospital de Câncer de Barretos-Unidade de Pesquisa Clínica ( Site 0437)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +551733216638
      • Pleven, Bulgaria, 5804
        • Reclutamento
        • MHAT - Heart and Brain ( Site 1006)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +35988030371
      • Plovdiv, Bulgaria, 4000
        • Reclutamento
        • Medical Center Futuremeds ( Site 1007)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +359886744494
      • Plovdiv, Bulgaria, 4004
        • Reclutamento
        • Complex Oncology Center - Plovdiv EOOD ( Site 1003)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +359 32 277 240
    • Pazardzhik
      • Panagyurishte, Pazardzhik, Bulgaria, 4500
        • Reclutamento
        • MBAL Uni Hospital-Department of Medical Oncology ( Site 1000)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +35935788581
    • Sofia (stolitsa)
      • Sofia, Sofia (stolitsa), Bulgaria, 1632
        • Reclutamento
        • Multiprofile Hospital for Active Treatment SerdikaМЕD EOOD-Second Department of Medical Oncology ( Site 1002)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +35929049100
    • Manitoba
      • Winnipeg, Manitoba, Canada, R3E 0V9
        • Reclutamento
        • CancerCare Manitoba ( Site 0210)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 204-787-4156
    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3H 2Y9
        • Reclutamento
        • QEII Health Sciences Centre - Victoria General Site-Dept. of Medical Oncology ( Site 0208)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 9024737964
    • Ontario
      • Hamilton, Ontario, Canada, L8V 5C2
        • Reclutamento
        • Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0205)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 9053879495
      • Toronto, Ontario, Canada, M4N 3M5
        • Reclutamento
        • Sunnybrook Research Institute ( Site 0206)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 4164805000x687435
    • Quebec
      • Montreal, Quebec, Canada, H3T 1M5
        • Reclutamento
        • St. Marys Hospital Center ( Site 0204)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 5143453511
      • Trois-Rivières, Quebec, Canada, G8Z 3R9
        • Reclutamento
        • Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec ( Site 0207)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 8196973333x63238
    • Maule Region
      • Talca, Maule Region, Chile, 3465584
        • Reclutamento
        • Clinica Universidad Catolica del Maule-Oncology ( Site 0500)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +56947532700
    • Region M. de Santiago
      • Santiago, Region M. de Santiago, Chile, 7500713
        • Reclutamento
        • Orlandi Oncologia-Oncology ( Site 0503)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +56226057491
      • Santiago, Region M. de Santiago, Chile, 7500921
        • Reclutamento
        • FALP-UIDO ( Site 0501)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +56224205098
      • Santiago, Region M. de Santiago, Chile, 8420383
        • Reclutamento
        • Bradfordhill-Clinical Area ( Site 0504)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +56229490970
      • Santiago, Region M. de Santiago, Chile, 7560913
        • Reclutamento
        • Centro de Oncología de Precisión ( Site 0502)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 56991612199
    • Anhui
      • Hefei, Anhui, Cina, 230031
        • Attivo, non reclutante
        • Anhui Provincial Cancer Hospital ( Site 3136)
    • Beijing Municipality
      • Beijing, Beijing Municipality, Cina, 100142
        • Attivo, non reclutante
        • Beijing Cancer hospital ( Site 3133)
      • Beijing, Beijing Municipality, Cina, 100142
        • Attivo, non reclutante
        • Beijing Cancer hospital ( Site 3134)
      • Beijing, Beijing Municipality, Cina, 100730
        • Attivo, non reclutante
        • Beijing Peking Union Medical College Hospital-pneumology department ( Site 3102)
      • Beijing, Beijing Municipality, Cina, 101149
        • Attivo, non reclutante
        • Beijing Chest Hospital,Capital Medical University ( Site 3104)
    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, Cina, 400030
        • Attivo, non reclutante
        • Chongqing University Cancer Hospital ( Site 3119)
      • Chongqing, Chongqing Municipality, Cina, 400042
        • Completato
        • Army Medical Center of People's Liberation Army ( Site 3142)
    • Fujian
      • Fuzhou, Fujian, Cina, 350014
        • Attivo, non reclutante
        • Fujian Cancer Hospital ( Site 3127)
      • Xiamen, Fujian, Cina, 361003
        • Attivo, non reclutante
        • The First Affiliated hospital of Xiamen University ( Site 3148)
    • Guangdong
      • Guangzhou, Guangdong, Cina, 510160
        • Completato
        • The First Affiliated Hospital of Guangzhou Medical University ( Site 3108)
      • Guangzhou, Guangdong, Cina, 510515
        • Attivo, non reclutante
        • Southern Medical University Nanfang Hospital ( Site 3128)
      • Guangzhou, Guangdong, Cina, 510555
        • Completato
        • Sun Yat-sen University Cancer Center ( Site 3137)
    • Heilongjiang
      • Harbin, Heilongjiang, Cina, 150081
        • Attivo, non reclutante
        • Harbin Medical University Cancer Hospital ( Site 3123)
      • Jiamusi, Heilongjiang, Cina, 154007
        • Attivo, non reclutante
        • JIAMUSI TUBERCULOSIS HOSPITAL(CANCER HOSPITAL) ( Site 3124)
    • Henan
      • Zhengzhou, Henan, Cina, 450008
        • Attivo, non reclutante
        • Henan Cancer Hospital ( Site 3149)
    • Hubei
      • Wuhan, Hubei, Cina, 430000
        • Attivo, non reclutante
        • Tongji Hospital Tongji Medical,Science & Technology ( Site 3113)
      • Wuhan, Hubei, Cina, 430079
        • Attivo, non reclutante
        • Hubei Cancer Hospital ( Site 3126)
    • Hunan
      • Changsha, Hunan, Cina, 410011
        • Completato
        • The Second Xiangya Hospital of Central South University ( Site 3130)
      • Changsha, Hunan, Cina, 410013
        • Attivo, non reclutante
        • Hunan Cancer Hospital ( Site 3141)
    • Jiangsu
      • Nanjing, Jiangsu, Cina, 210008
        • Attivo, non reclutante
        • Nanjing Gulou Hospital ( Site 3122)
      • Nanjing, Jiangsu, Cina, 210012
        • Completato
        • Nanjing First Hospital ( Site 3154)
      • Suzhou, Jiangsu, Cina, 215006
        • Completato
        • The First Affiliated Hospital of Soochow University ( Site 3146)
      • Wuxi, Jiangsu, Cina, 214122
        • Attivo, non reclutante
        • Affiliated Hospital of Jiangnan University(Wuxi Fourth People's Hospital ) ( Site 3155)
    • Jiangxi
      • Nanchang, Jiangxi, Cina, 330000
        • Completato
        • The Second Affiliated Hospital of Nanchang University ( Site 3139)
      • Nanchang, Jiangxi, Cina, 330006
        • Attivo, non reclutante
        • The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 3138)
    • Jilin
      • Changchun, Jilin, Cina, 130012
        • Attivo, non reclutante
        • Jilin Province Tumor Hospital ( Site 3107)
    • Shaanxi
      • Xi'an, Shaanxi, Cina, 710000
        • Completato
        • The First Affiliated Hospital of Xi'an Jiaotong University ( Site 3150)
    • Shandong
      • Jinan, Shandong, Cina, 250117
        • Attivo, non reclutante
        • Shandong Cancer Hospital ( Site 3116)
      • Linyi, Shandong, Cina, 276001
        • Attivo, non reclutante
        • LinYi Cancer Hospital ( Site 3111)
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Cina, 200030
        • Attivo, non reclutante
        • Shanghai Chest Hospital ( Site 3100)
      • Shanghai, Shanghai Municipality, Cina, 200032
        • Attivo, non reclutante
        • Fudan University Shanghai Cancer Center ( Site 3144)
      • Shanghai, Shanghai Municipality, Cina, 200032
        • Attivo, non reclutante
        • Zhongshan Hospital,Fudan University ( Site 3143)
    • Shanxi
      • Taiyuan, Shanxi, Cina, 030000
        • Attivo, non reclutante
        • Shanxi Cancer Hospital ( Site 3131)
      • Xian, Shanxi, Cina, 710038
        • Completato
        • The Second Affiliated Hospital of Air Force Medical University ( Site 3117)
      • Xian, Shanxi, Cina, 710038
        • Attivo, non reclutante
        • The Second Affiliated Hospital of Air Force Medical University ( Site 3152)
    • Sichuan
      • Chengdu, Sichuan, Cina, 610000
        • Attivo, non reclutante
        • West China Hospital, Sichuan University ( Site 3140)
      • Chengdu, Sichuan, Cina, 610031
        • Attivo, non reclutante
        • The Third People's Hospital of Chengdu (CDTPH) ( Site 3157)
      • Chengdu, Sichuan, Cina, 610042
        • Attivo, non reclutante
        • Sichuan Cancer hospital. ( Site 3109)
      • Neijiang, Sichuan, Cina, 641000
        • Attivo, non reclutante
        • The Second People's Hospital of Neijiang ( Site 3105)
    • Xinjiang
      • Ürümqi, Xinjiang, Cina, 830000
        • Completato
        • Xinjiang Medical University Cancer Hospital - Urumqi ( Site 3101)
    • Yunnan
      • Kunming, Yunnan, Cina, 650107
        • Attivo, non reclutante
        • Yunnan Province Cancer Hospital ( Site 3153)
    • Zhejiang
      • Hangzhou, Zhejiang, Cina, 310006
        • Attivo, non reclutante
        • The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 3115)
      • Hangzhou, Zhejiang, Cina, 310016
        • Attivo, non reclutante
        • Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 3121)
      • Linhai, Zhejiang, Cina, 317000
        • Attivo, non reclutante
        • Taizhou Hospital of Zhejiang Province ( Site 3145)
      • Wenzhou, Zhejiang, Cina, 325015
        • Attivo, non reclutante
        • The First Affiliated Hospital of Wenzhou Medical University ( Site 3151)
    • Cesar Department
      • Valledupar, Cesar Department, Colombia, 200001
        • Reclutamento
        • Sociedad De Oncología y Hematología Del Cesar SAS ( Site 4000)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +573122354788
    • Cundinamarca
      • Bogota, Cundinamarca, Colombia, 110111
        • Reclutamento
        • Clinica Oncologica Colsubsidio ( Site 4003)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +573142059194
    • Risaralda Department
      • Pereira, Risaralda Department, Colombia, 660001
        • Reclutamento
        • Oncologos del Occidente ( Site 4005)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +57 3187715522
    • Valle del Cauca Department
      • Cali, Valle del Cauca Department, Colombia, 76001
        • Reclutamento
        • Hemato Oncologos SA ( Site 4002)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +573167711932
      • Incheon, Corea del Sud, 22332
        • Reclutamento
        • Inha University Hospital ( Site 3610)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +82328901038
      • Seoul, Corea del Sud, 02447
        • Reclutamento
        • Kyung Hee University Hospital ( Site 3605)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 82-2-958-8511
      • Seoul, Corea del Sud, 08308
        • Reclutamento
        • Korea University Guro Hospital ( Site 3601)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +82226261914
      • Seoul, Corea del Sud, 03312
        • Reclutamento
        • The Catholic University of Korea, Eunpyeong St. Mary's Hospital ( Site 3608)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +82220304340
      • Seoul, Corea del Sud, 02841
        • Reclutamento
        • Korea University Anam Hospital ( Site 3609)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +8229206409
    • Incheon
      • Bupyeong-gu, Incheon, Corea del Sud, 21431
        • Reclutamento
        • The Catholic University of Korea, Incheon St. Mary's Hospital ( Site 3606)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +82-32-280-6474
    • Jeonranamdo
      • Hwasun, Jeonranamdo, Corea del Sud, 58128
        • Completato
        • Chonnam National University Hwasun Hospital-Pulmonology ( Site 3604)
    • Kyonggi-do
      • Suwon, Kyonggi-do, Corea del Sud, 16247
        • Reclutamento
        • The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 3600)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 82-31-244-7983
    • Kyongsangnam-do
      • Yangsan, Kyongsangnam-do, Corea del Sud, 50612
        • Reclutamento
        • Pusan National University Yangsan Hospital-Lung Cancer Clinic ( Site 3603)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +82-55-360-1415
    • Taegu-Kwangyokshi
      • Daegu, Taegu-Kwangyokshi, Corea del Sud, 42415
        • Reclutamento
        • Yeungnam University Hospital ( Site 3607)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +82536203848
      • Daegu, Taegu-Kwangyokshi, Corea del Sud, 42601
        • Reclutamento
        • Keimyung University Dongsan Hospital ( Site 3611)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +82532587737
    • Taejon-Kwangyokshi
      • Junggu, Taejon-Kwangyokshi, Corea del Sud, 35015
        • Reclutamento
        • Chungnam national university hospital ( Site 3602)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 82-42-257-5753
      • San José, Costa Rica, 10103
        • Reclutamento
        • Onco Tech, S.A. ( Site 4102)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +50622586260
    • National Capital Region
      • Pasig, National Capital Region, Filippine, 1600
        • Reclutamento
        • The Medical City ( Site 3507)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: (02)6356789 loc 5083
      • Quezon City, National Capital Region, Filippine, 1100
        • Reclutamento
        • Lung Center of the Philippines-Pulmonary, Critical Care and Sleep Medicine ( Site 3503)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +632 892 46101*1309
      • Quezon City, National Capital Region, Filippine, 1102
        • Reclutamento
        • ST. LUKE'S MEDICAL CENTER-Medical oncology ( Site 3501)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +63287230101
      • Quezon City, National Capital Region, Filippine, 1100
        • Completato
        • Veterans Memorial Medical Center-Section of Oncology ( Site 3505)
    • Alpes-Maritimes
      • Nice, Alpes-Maritimes, Francia, 06000
        • Reclutamento
        • Centre Hospitalier Universitaire de Nice - Hopital Pasteur ( Site 1108)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +33492038281
    • Bourgogne-Franche-Comté
      • Dijon, Bourgogne-Franche-Comté, Francia, 21000
        • Reclutamento
        • Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital François Mitterrand ( Site 1103)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +33380293772
    • Finistere
      • Quimper, Finistere, Francia, 29107
        • Reclutamento
        • Centre Hospitalier de Cornouaille Quimper - Concarneau ( Site 1107)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 33899282481
    • Gard
      • Nîmes, Gard, Francia, 30029
        • Reclutamento
        • Centre Hospitalier Universitaire de Nîmes - Institut de Cancérologie du Gard - Hôpital Universitaire ( Site 1106)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +33 4 66 68 32 21
    • Nord
      • Valenciennes, Nord, Francia, 59304
        • Reclutamento
        • Clinique Teissier Groupe ( Site 1100)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +33327142337
    • Puy-de-Dome
      • Clermont-Ferrand, Puy-de-Dome, Francia, 63003
        • Reclutamento
        • Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne-ONCOLOGY ( Site 1101)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +33473278005
    • Vaucluse
      • Avignon, Vaucluse, Francia, 84000
        • Reclutamento
        • Centre Hospitalier d'Avignon-Service d'Oncologie médicale et d'hématologie clinique ( Site 1104)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +33432753333
    • Île-de-France Region
      • Boulogne-Billancourt, Île-de-France Region, Francia, 92100
        • Reclutamento
        • Hôpital Ambroise Paré-Department of Respiratory Diseases and Thoracic Oncology ( Site 1105)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +33149095806
      • Tbilisi, Georgia, 0112
        • Reclutamento
        • Todua Clinic, LLC ( Site 1204)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +995322575757
      • Tbilisi, Georgia, 0162
        • Reclutamento
        • New Hospitals ( Site 1200)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +995 598 988 566
      • Tbilisi, Georgia, 0177
        • Reclutamento
        • Cancer Research Centre. Mardaleishvili Medical Centre ( Site 1205)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +995322430100
      • Tbilisi, Georgia, 0102
        • Reclutamento
        • American Hospital Network LLC ( Site 1208)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +995 571 300 705
      • Tbilisi, Georgia, 1206
        • Completato
        • Tbilisi Institute of Medicine ( Site 1206)
      • Tbilisi, Georgia, 0144
        • Completato
        • TSMU and Ingorokva High Medical Technology University Clinic LTD ( Site 1201)
      • Tbilisi, Georgia, 0159
        • Reclutamento
        • "Institute of Clinical Oncology" LTD ( Site 1210)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +995599406920
    • Adjara
      • Batumi, Adjara, Georgia, 6000
        • Reclutamento
        • High Technology Hospital Medcenter ( Site 1203)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +995596226060
      • Tbilisi, Adjara, Georgia, 0186
        • Reclutamento
        • Caucasus Medical Centre ( Site 1202)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +995 597 550 140
    • Imereti
      • Kutaisi, Imereti, Georgia, 4600
        • Reclutamento
        • JSC "Vian" ( Site 1211)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +995599705858
    • Baden-Wurttemberg
      • Stuttgart, Baden-Wurttemberg, Germania, 70199
        • Reclutamento
        • Marienhospital Stuttgart ( Site 1302)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +49711064893273
    • Mecklenburg-Vorpommern
      • Greifswald, Mecklenburg-Vorpommern, Germania, 17489
        • Reclutamento
        • Universitätsmedizin Greifswald ( Site 1308)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +4938348622006
    • North Rhine-Westphalia
      • Bielefeld, North Rhine-Westphalia, Germania, 33611
        • Reclutamento
        • Evangelisches Krankenhaus Bielefeld - Johannesstift ( Site 1307)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 0521 772 75504
      • Solingen, North Rhine-Westphalia, Germania, 42699
        • Reclutamento
        • Krankenhaus Bethanien ( Site 1303)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +49212636661
      • Chiba, Giappone, 260-8677
        • Reclutamento
        • Chiba University Hospital ( Site 3322)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-43-222-7171
      • Hiroshima, Giappone, 730-8518
        • Reclutamento
        • Hiroshima City Hiroshima Citizens Hospital ( Site 3314)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-82-221-2291
      • Kumamoto, Giappone, 861-4193
        • Reclutamento
        • Saiseikai Kumamoto Hospital ( Site 3318)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-96-351-8000
      • Niigata, Giappone, 951-8520
        • Reclutamento
        • Niigata University Medical & Dental Hospital ( Site 3323)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-25-223-6161
      • Osaka, Giappone, 545-8586
        • Reclutamento
        • Osaka Metropolitan University Hospital ( Site 3321)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-6-6645-2121
    • Aichi-ken
      • Nagoya, Aichi-ken, Giappone, 466-8560
        • Reclutamento
        • Nagoya University Hospital ( Site 3309)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-52-741-2111
      • Toyoake, Aichi-ken, Giappone, 470-1192
        • Reclutamento
        • Fujita Health University Hospital ( Site 3310)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-562-93-2111
    • Chiba
      • Kashiwa, Chiba, Giappone, 277-8577
        • Reclutamento
        • National Cancer Center Hospital East ( Site 3303)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-4-7133-1111
    • Ehime
      • Matsuyam, Ehime, Giappone, 719-0280
        • Reclutamento
        • National Hospital Organization Shikoku Cancer Center ( Site 3315)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-89-999-1111
    • Fukuoka
      • Fukuoka, Fukuoka, Giappone, 811-1395
        • Reclutamento
        • National Hospital Organization Kyushu Cancer Center ( Site 3316)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-92-541-3231
      • Kurume, Fukuoka, Giappone, 830-0011
        • Reclutamento
        • Kurume University Hospital ( Site 3317)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-942-35-3311
    • Gunma
      • Ōta, Gunma, Giappone, 373-8550
        • Reclutamento
        • Gunma Prefectural Cancer Center ( Site 3302)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-276-38-0771
    • Hokkaido
      • Sapporo, Hokkaido, Giappone, 060-8543
        • Reclutamento
        • Sapporo Medical University Hospital ( Site 3324)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-11-611-2111
    • Ishikawa-ken
      • Kanazawa, Ishikawa-ken, Giappone, 920-8641
        • Reclutamento
        • Kanazawa University Hospital ( Site 3308)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-76-265-2000
    • Kanagawa
      • Kawasaki, Kanagawa, Giappone, 216-8511
        • Reclutamento
        • St. Marianna University Hospital ( Site 3320)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-44-977-8111
    • Mie-ken
      • Matsusaka, Mie-ken, Giappone, 515-8544
        • Reclutamento
        • Saiseikai Matsusaka Municipal Hospital ( Site 3311)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-598-23-1515
    • Miyagi
      • Natori-shi, Miyagi, Giappone, 981-1293
        • Reclutamento
        • Miyagi Cancer Center ( Site 3301)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-22-384-3151
      • Sendai, Miyagi, Giappone, 981-0914
        • Reclutamento
        • Sendai Kousei Hospital ( Site 3300)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-22-222-6181
    • Osaka
      • Hirakata, Osaka, Giappone, 573-1191
        • Reclutamento
        • Kansai Medical University Hospital ( Site 3312)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-72-804-0101
      • Takatsuki, Osaka, Giappone, 569-8686
        • Reclutamento
        • Osaka Medical and Pharmaceutical University Hospital ( Site 3313)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-72-683-1221
    • Saitama
      • Kitaadachi-gun, Saitama, Giappone, 362-0806
        • Reclutamento
        • Saitama Prefectural Cancer Center ( Site 3304)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-48-722-1111
    • Tokyo
      • Bunkyo, Tokyo, Giappone, 113-8603
        • Reclutamento
        • Nippon Medical School Hospital ( Site 3306)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-3-3822-2131
      • Shinjuku, Tokyo, Giappone, 160-0023
        • Reclutamento
        • Tokyo Medical University Hospital ( Site 3307)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-3-3342-6111
      • Shinjuku, Tokyo, Giappone, 162-8655
        • Reclutamento
        • National Center for Global Health and Medicine ( Site 3305)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-3-3202-7181
      • Ōta-ku, Tokyo, Giappone, 143-8541
        • Reclutamento
        • Toho University Omori Medical Center ( Site 3319)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +81-3-3762-4151
      • Thessaloniki, Grecia, 570 10
        • Reclutamento
        • G. Papanikolaou General Hospital-Pulmonary Clinic of Aristotle University of Thessaloniki ( Site 1405)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 0030 231330787476
      • Thessaloniki, Grecia, 570 01
        • Reclutamento
        • European Interbalkan Medical Center ( Site 1404)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +302310380000
    • Achaia
      • Pátrai, Achaia, Grecia, 26504
        • Reclutamento
        • UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 1402)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +302610999791
    • Attica
      • Athens, Attica, Grecia, 115 27
        • Reclutamento
        • THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 1400)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +302107700220
      • Athens, Attica, Grecia, 115 22
        • Reclutamento
        • Agios Savvas Regional Cancer Hospital-2nd Medical Oncology Department ( Site 1407)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +302106409501
      • Marousi, Attica, Grecia, 151 25
        • Reclutamento
        • Athens Medical Center ( Site 1406)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +302107464642
      • Piraeus, Attica, Grecia, 185 37
        • Reclutamento
        • Metaxa Cancer Hospital of Piraeus ( Site 1408)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +302132079225
    • Thessaly
      • Larissa, Thessaly, Grecia, 411 10
        • Reclutamento
        • University General Hospital of Larissa-Oncology Clinic ( Site 1403)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +302413502124
    • Maharashtra
      • Mumbai, Maharashtra, India, 400012
        • Reclutamento
        • Tata Memorial Hospital ( Site 3205)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 02224177000
      • Mumbai, Maharashtra, India, 400004
        • Attivo, non reclutante
        • Sir H. N. Reliance Foundation Hospital and Research Centre ( Site 3201)
    • National Capital Territory of Delhi
      • New Delhi, National Capital Territory of Delhi, India, 110076
        • Reclutamento
        • Indraprastha Apollo Hospitals-APOLLO RESEARCH INNOVATION ( Site 3203)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +919426166688
      • New Delhi, National Capital Territory of Delhi, India, 110029
        • Reclutamento
        • AIIMS New Delhi Dept of Medicine ( Site 3206)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +91-9650629370
      • Padova, Italia, 35131
        • Reclutamento
        • IOV - Istituto Oncologico Veneto IRCCS UOSD - Unità di ricerca clinica ( Site 1603)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +390498215649
    • Campania
      • Naples, Campania, Italia, 80131
        • Reclutamento
        • Istituto Nazionale Tumori IRCCS Fondazione Pascale-Oncologia clinica sperimentale Toraco-Polmonare ( Site 1607)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +390811777029
    • Emilia-Romagna
      • Ravenna, Emilia-Romagna, Italia, 48121
        • Reclutamento
        • Ospedale Santa Maria delle Croci ( Site 1606)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +390544285247
    • Friuli Venezia Giulia
      • Aviano, Friuli Venezia Giulia, Italia, 33081
        • Reclutamento
        • CRO-IRCCS-Clinical Oncology ( Site 1605)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +390434309464
    • Lazio
      • Rome, Lazio, Italia, 00168
        • Reclutamento
        • Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1601)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 00390630156318
    • Lombardy
      • Milan, Lombardy, Italia, 20133
        • Reclutamento
        • Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1600)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +390223903829
      • Milan, Lombardy, Italia, 20141
        • Reclutamento
        • Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 1604)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +390257489482
    • Napoli
      • Naples, Napoli, Italia, 80131
        • Reclutamento
        • A.O.R.N. Ospedale dei Colli - Monaldi V.-U.O.C Pneumologia Oncologica DH PNL ONC ( Site 1602)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 0817062652
    • Roma
      • Rome, Roma, Italia, 00144
        • Reclutamento
        • Istituto Nazionale Tumori Regina Elena-Oncologia Medica 2 ( Site 1609)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +390652662205
    • Tuscany
      • Livorno, Tuscany, Italia, 57124
        • Reclutamento
        • Azienda USL Toscana Nord Ovest_Ospedale Civile di Livorno-UOC Oncologia Medica Livorno ( Site 1608)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 00390586223416
      • México, Messico, 14080
        • Reclutamento
        • Instituto Nacional de Cancerologia. ( Site 0608)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +525556280400
      • Oaxaca City, Messico, 68000
        • Reclutamento
        • Oaxaca Site Management Organization S.C. ( Site 0603)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +529515147056
      • Querétaro, Messico, 76070
        • Reclutamento
        • SMIQ ( Site 0609)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +52 442 224 7516
    • Mexico City
      • Mexico City, Mexico City, Messico, 06700
        • Reclutamento
        • Arké SMO S.A. de C.V. ( Site 0602)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 5533345856
      • Mexico City, Mexico City, Messico, 3100
        • Reclutamento
        • SUPERARE CENTRO DE INFUSION SA DE CV ( Site 0610)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +52 55 5264 6440
    • Nuevo León
      • Monterrey, Nuevo León, Messico, 66460
        • Reclutamento
        • Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Hematologia and Oncologia ( Site 0600)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +528180883663
      • Auckland, Nuova Zelanda, 1023
        • Reclutamento
        • Auckland City Hospital ( Site 3400)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +6493074949
      • Utrecht, Olanda, 3584 CX
        • Reclutamento
        • Universitair Medisch Centrum Utrecht ( Site 1704)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 00318875555555
    • Gelderland
      • Ede, Gelderland, Olanda, 6716 RP
        • Reclutamento
        • Ziekenhuis Gelderse Vallei ( Site 1705)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 0318435499
      • Harderwijk, Gelderland, Olanda, 3844 DG
        • Reclutamento
        • Ziekenhuis St. Jansdal-Poli Longziekten ( Site 1701)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 0031341463504
    • Overijssel
      • Hengelo, Overijssel, Olanda, 7555 DL
        • Reclutamento
        • Ziekenhuisgroep Twente, locatie Almelo ( Site 1706)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +31887087878
      • Zwolle, Overijssel, Olanda, 8025 AB
        • Reclutamento
        • Isala, locatie Zwolle-Poli Longziekten ( Site 1700)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 0031886243254
      • Lima, Perù, 15036
        • Reclutamento
        • IPOR Instituto Peruano de Oncología & Radioterapia ( Site 4301)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 511 2241598 anex 121
    • Lesser Poland Voivodeship
      • Gorlice, Lesser Poland Voivodeship, Polonia, 38-300
        • Completato
        • Szpital Specjalistyczny im. Henryka Klimontowicza ( Site 1801)
      • Krakow, Lesser Poland Voivodeship, Polonia, 30-727
        • Completato
        • Pratia MCM Krakow ( Site 1808)
    • Lublin Voivodeship
      • Lublin, Lublin Voivodeship, Polonia, 20-090
        • Reclutamento
        • Uniwersytecki Szpital Kliniczny nr 4 w Lublinie ( Site 1805)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +48 814485180
    • Podkarpackie Voivodeship
      • Przemyśl, Podkarpackie Voivodeship, Polonia, 37-700
        • Reclutamento
        • Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1804)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +48166775000
    • Warmian-Masurian Voivodeship
      • Olsztyn, Warmian-Masurian Voivodeship, Polonia, 10-357
        • Reclutamento
        • Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie ( Site 1809)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +48895322978
    • Buckinghamshire
      • Milton Keynes, Buckinghamshire, Regno Unito, MK6 5LD
        • Reclutamento
        • Milton Keynes Hospital ( Site 2304)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 01908 997609
    • Devon
      • Exeter, Devon, Regno Unito, EX2 5DW
        • Reclutamento
        • Royal Devon & Exeter Hospital-Oncology ( Site 2302)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +44 (0) 1392 402869
      • Brasov, Romania, 500052
        • Reclutamento
        • SC ONCO CARD SRL ( Site 1995)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +40268 994
      • Bucharest, Romania, 077190
        • Reclutamento
        • SC MNT HEALTHCARE EUROPE SRL ( Site 1991)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +40722927377
      • Cluj-Napoca, Romania, 400015
        • Reclutamento
        • Institutul Oncologic Cluj-Oncologie Medicala ( Site 1999)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +40264598362
      • Suceava, Romania, 720214
        • Reclutamento
        • Sigmedical Services SRL ( Site 1997)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +4 0330 803 483
    • Bucharest
      • Bucharest, Bucharest, Romania, 020335
        • Reclutamento
        • Centrul de Diagnostic si Tratament Provita. ( Site 1992)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +4021.9432
    • Dolj
      • Craiova, Dolj, Romania, 200542
        • Reclutamento
        • Centrul de Oncologie Sfantul Nectarie-Medical ( Site 1994)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +40731604432
    • Timiș County
      • Timișoara, Timiș County, Romania, 300239
        • Reclutamento
        • Cabinet Medical Oncomed ( Site 1998)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +40356460995
      • Barcelona, Spagna, 08035
        • Reclutamento
        • Hospital Universitari Vall d Hebron ( Site 2010)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +34 932 543 450
      • Madrid, Spagna, 28040
        • Reclutamento
        • Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 2017)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 34915504800x253900
      • Madrid, Spagna, 28006
        • Reclutamento
        • Hospital Universitario La Princesa ( Site 2020)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +34915202200
      • Málaga, Spagna, 29010
        • Reclutamento
        • Hospital Universitario Virgen de la Victoria ( Site 2021)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 0034671594566
      • Seville, Spagna, 41009
        • Reclutamento
        • Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 2015)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 34954712941
    • Barcelona
      • Vic, Barcelona, Spagna, 08500
        • Reclutamento
        • H. General de Vic ( Site 2022)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +34937027732
    • Las Palmas
      • Las Palmas de Gran Canaria, Las Palmas, Spagna, 35001
        • Reclutamento
        • Hospital Insular de Gran Canaria-Oncology ( Site 2019)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +34 928441738
    • Madrid, Comunidad de
      • Leganés, Madrid, Comunidad de, Spagna, 28911
        • Reclutamento
        • Hospital Universitario Severo Ochoa ( Site 2024)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +34914818000
      • Madrid, Madrid, Comunidad de, Spagna, 28009
        • Reclutamento
        • HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON-ONCOLOGY ( Site 2012)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +34 915868115
    • Malaga
      • Málaga, Malaga, Spagna, 29011
        • Reclutamento
        • H.R.U Málaga - Hospital General-Oncology ( Site 2014)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +34 951308130
    • California
      • Bakersfield, California, Stati Uniti, 93309
        • Reclutamento
        • CBCC Global Research, Inc. ( Site 0123)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 661-322-2206
      • Beverly Hills, California, Stati Uniti, 90211
        • Reclutamento
        • Beverly Hills Cancer Center ( Site 0116)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 310-432-8955
    • Connecticut
      • Stamford, Connecticut, Stati Uniti, 06902
        • Reclutamento
        • Stamford Hospital ( Site 0136)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 877-233-9355
    • Florida
      • Miami Beach, Florida, Stati Uniti, 33140
        • Completato
        • Mount Sinai Cancer Center ( Site 0137)
    • Illinois
      • Skokie, Illinois, Stati Uniti, 60077
        • Reclutamento
        • Orchard Healthcare Research Inc. ( Site 0115)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 224-534-7580
    • Missouri
      • Kansas City, Missouri, Stati Uniti, 64108
        • Reclutamento
        • Truman Medical Center ( Site 0126)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 816-404-4093
      • Springfield, Missouri, Stati Uniti, 65807
        • Reclutamento
        • Cox Medical Center North ( Site 0133)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 417-875-3000
    • Montana
      • Billings, Montana, Stati Uniti, 59102
        • Reclutamento
        • St. Vincent Frontier Cancer Center-Research ( Site 0105)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 402-238-6685
    • New Jersey
      • Morristown, New Jersey, Stati Uniti, 07960
        • Completato
        • Atlantic Health System Morristown Medical Center ( Site 0121)
    • New York
      • Albany, New York, Stati Uniti, 12206
        • Reclutamento
        • New York Oncology Hematology, P.C. ( Site 0132)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 518-489-3612
    • Ohio
      • Cincinnati, Ohio, Stati Uniti, 45219
        • Reclutamento
        • University of Cincinnati Medical Center-University of Cincinnati Cancer Center ( Site 0103)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 513-556-6000
      • Kettering, Ohio, Stati Uniti, 45429
        • Completato
        • Kettering Health Main Campus-Kettering Health Cancer Center ( Site 0106)
    • Pennsylvania
      • Lancaster, Pennsylvania, Stati Uniti, 17601
        • Reclutamento
        • Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0134)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 717-544-9400
    • Texas
      • Houston, Texas, Stati Uniti, 77030
        • Reclutamento
        • Oncology Consultants P.A. ( Site 0113)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 713-600-0900
    • Wisconsin
      • Madison, Wisconsin, Stati Uniti, 53715
        • Reclutamento
        • Circuit Clinical/SSM Health Dean Medical Group ( Site 0129)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: 608-410-2767
      • Adana, Turchia (Türkiye), 01140
        • Reclutamento
        • Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 2107)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +90 322 456 19 00
      • Ankara, Turchia (Türkiye), 06010
        • Reclutamento
        • SBU GULHANE EGITIM VE ARASTIRMA HASTANESI Onkoloji ( Site 2104)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +905058726378
      • Ankara, Turchia (Türkiye), 06230
        • Reclutamento
        • Hacettepe Universite Hastaneleri-oncology hospital ( Site 2101)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +90 312 305 10 80
      • Ankara, Turchia (Türkiye), 06520
        • Reclutamento
        • Memorial Ankara Hastanesi-Medical Oncology ( Site 2106)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +903122536666
      • Ankara, Turchia (Türkiye), 06800
        • Reclutamento
        • Ankara Bilkent Şehir Hastanesi ( Site 2100)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +903125526000
      • Istanbul, Turchia (Türkiye), 34214
        • Reclutamento
        • Medipol Mega Universite Hastanesi-oncology ( Site 2105)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +902124447044
      • Istanbul, Turchia (Türkiye), 34722
        • Reclutamento
        • TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2103)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +902166065200
      • Sakarya, Turchia (Türkiye), 54290
        • Reclutamento
        • Sakarya Training and Research Hospital ( Site 2109)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +902648884000
    • İzmir
      • Balçova, İzmir, Turchia (Türkiye), 35340
        • Reclutamento
        • Dokuz Eylul Universitesi Hastanesi ( Site 2108)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +902323434343
      • Bornova, İzmir, Turchia (Türkiye), 35100
        • Reclutamento
        • Ege Universitesi Hastanesi-Chest Diseases Department ( Site 2102)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +905322202675
    • Cherkasy Oblast
      • Cherkasy, Cherkasy Oblast, Ucraina, 18009
        • Completato
        • COMMUNAL NONPROFIT ENTERPRISE CLINICAL CENTER OF ONCOLOGY, HEMATOLOGY, TRANSPLANTOLOGY AND PALLIATI ( Site 2209)
    • Chernivetska Oblast
      • Chernivtsi, Chernivetska Oblast, Ucraina, 58013
        • Reclutamento
        • Regional Municipal Non-profit Enterprise "Bukovinian Clinical Oncology Center" ( Site 2210)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +380955077568
    • Dnipropetrovsk Oblast
      • Kryvyi Rih, Dnipropetrovsk Oblast, Ucraina, 50000
        • Reclutamento
        • Medical Center "Mriya Med-Service"-Clinical Research Department ( Site 2215)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +380973567855
    • Ivano-Frankivsk Oblast
      • Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ucraina, 76018
        • Reclutamento
        • Communal Non-Commercial Enterprise "Prykarpatski Clinical On-Surgery department #2 ( Site 2202)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +380978411455
    • Kirovohrad Oblast
      • Kropyvnytskyi, Kirovohrad Oblast, Ucraina, 25011
        • Reclutamento
        • Kirovohrad Regional Oncology Center-Chemotherapy department ( Site 2204)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +380508412400
    • Kyivska Oblast
      • Kiev, Kyivska Oblast, Ucraina, 03022
        • Reclutamento
        • Medical Center "MedOffice Group" ( Site 2219)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +380503858689
      • Kyiv, Kyivska Oblast, Ucraina, 03039
        • Reclutamento
        • LLC Clinic Verum Expert ( Site 2223)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +380443835959
    • Lviv Oblast
      • Lviv, Lviv Oblast, Ucraina, 79059
        • Reclutamento
        • Lviv Territorial Medical Union Multidisciplinary Clinical Hospital ( Site 2217)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +380506749772
    • Rivne Oblast
      • Rivne, Rivne Oblast, Ucraina, 33007
        • Completato
        • Rivne Regional Clinical Hospital ( Site 2205)
      • Rivne, Rivne Oblast, Ucraina, 33010
        • Reclutamento
        • ME RIVNE REGIONAL ANTITUMOR CENTER ( Site 2920)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +380362633075
    • Vinnytsia Oblast
      • Vinnytsia, Vinnytsia Oblast, Ucraina, 21029
        • Reclutamento
        • Communal Noncommercial Enterprise "Podillia Regional Oncolog-Cardiothoracic department ( Site 2211)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +380953105783
    • Volyn Oblast
      • Lutsk, Volyn Oblast, Ucraina, 43018
        • Reclutamento
        • ME Volyn Regional Clinical Hospital of the Volyn Regional Council ( Site 2216)
        • Contatto:
          • Study Coordinator
          • Numero di telefono: +380503782998

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

The main inclusion and exclusion criteria include but are not limited to the following:

Inclusion Criteria:

  • Has histologically or cytologically confirmed diagnosis of non-small cell lung cancer (NSCLC)
  • Has newly diagnosed Stage IIIB/IIIC NSCLC, not eligible for curative resection or curative chemotherapy/radiation as determined by a multidisciplinary tumor board and/or by radiation oncologist, surgeon, and medical oncologist or Stage IV (M1a, M1b, or M1c) by American Joint Committee on Cancer (AJCC) Staging Manual, Version 8
  • Provides an archival tumor sample (≤5 years) or newly obtained core, incisional, or excisional biopsy or fine needle aspirate (FNA) of a tumor lesion, not previously irradiated to enable central laboratory testing of kirsten rat sarcoma (KRAS) G12C mutation status, programmed cell death ligand 1 (PD-L1) status, and biomarker research
  • If have had adverse events (AEs) due to previous anticancer therapies, must have recovered to < Grade 1 or baseline
  • If human immunodeficiency virus (HIV)-infected, must have well controlled HIV on antiretroviral therapy (ART)
  • If Hepatitis B surface antigen (HBsAg) positive, have received Hepatitis B Virus (HBV) antiviral therapy for at least 4 weeks, and have undetectable HBV viral load
  • If a participant has a history of Hepatitis C virus (HCV) infection, HCV viral load is undetectable

Exclusion Criteria:

  • Has diagnosis of small cell lung cancer. For mixed tumors, if small cell elements are present, the participant is ineligible
  • Has active inflammatory bowel disease requiring immunosuppressive medication or previous clear history of inflammatory bowel disease
  • Has known history of, or active, neurologic paraneoplastic syndrome
  • Has an active infection requiring systemic therapy, with exceptions
  • Has uncontrolled, significant cardiovascular disease or cerebrovascular disease
  • Has received prior systemic anticancer therapy for their locally advanced or metastatic NSCLC
  • Has received radiation therapy to the lung that is >30 Gray within 6 months of start of study intervention
  • Has received radiotherapy to non-central nervous system (CNS) disease within 2 weeks of start of study intervention. Participants must have recovered from all radiation-related toxicities, not required corticosteroids, and not have had radiation pneumonitis
  • Has known active CNS metastases and/or carcinomatous meningitis
  • Known additional malignancy that is progressing or has required active treatment within the past 3 years
  • Has active autoimmune disease that has required systemic treatment in the past 2 years
  • Has history of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease
  • Is HIV-infected and has a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease
  • Has history of allogenic tissue/solid organ transplant
  • Has not fully recovered from any effects of major surgical procedure

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Triplicare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Calderasib with Pembrolizumab

Participants receive pembrolizumab 200 mg via intravenous (IV) infusion on Day 1 of each 21-day cycle (q3w) for up to 35 cycles and calderasib by oral tablets until discontinuation criterion is met.

IV infusion

Altri nomi:
  • MK-3475
  • KEYTRUDA®

Oral tablets

Altri nomi:
  • MK-1084
Comparatore attivo: Placebo with Pembrolizumab

Participants receive pembrolizumab 200 mg via intravenous (IV) infusion on Day 1 of each 21-day cycle (q3w) for up to 35 cycles and placebo by oral tablets once daily until discontinuation criterion is met.

IV infusion

Altri nomi:
  • MK-3475
  • KEYTRUDA®

Oral tablets

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Progression-Free Survival (PFS)
Lasso di tempo: Up to approximately 42 months

PFS is defined as the time from randomization until either documented disease progression per Response Criteria in Solid Tumors Version 1.1 (RECIST 1.1) or death due to any cause, whichever occurs first. PFS as determined by blinded independent central review (BICR) will be presented.

Up to approximately 42 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Overall Survival
Lasso di tempo: Up to approximately 57 months

OS is defined as the time from randomization to death due to any cause.

Up to approximately 57 months
Objective Response Rate (ORR)
Lasso di tempo: Up to approximately 42 months

ORR is defined as the percentage of participants with Complete Response or Partial Response per RECIST1.1. The percentage of participants who experience CR or PR as assessed by BICR will be presented.

Up to approximately 42 months
Duration of Response (DOR)
Lasso di tempo: Up to approximately 42 months

For participants who demonstrate confirmed CR or PR per RECIST 1.1 as assessed by BICR, duration of response is defined as the time from the first documented evidence of CR or PR until disease progression or death due to any cause, whichever occurs first.

Up to approximately 42 months
Number of Participants Who Experience One or More Adverse Event (AEs)
Lasso di tempo: Up to approximately 80 months

An AE is any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE. The number of participants who experience an AE will be presented.

Up to approximately 80 months
Number of Participants Who Discontinue Study Treatment Due to an Adverse Event (AE)
Lasso di tempo: Up to approximately 80 months

An AE is any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE. The number of participants who discontinue study treatment due to an AE will be presented.

Up to approximately 80 months
Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) Global Health Status (Item 29) and Quality of Life (Item 30) Combined Score
Lasso di tempo: Baseline and Up to approximately 24 months

The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to the questions "How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?" are scored on a 7-point scale (1= Very poor to 7=Excellent). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The change from baseline in the score of EORTC QLQ-C30 Items 29 and 30 will be presented. Higher scores indicate a better overall health status.

Baseline and Up to approximately 24 months
Change From Baseline in EORTC QLQ-C30 Physical Functioning (Items 1-5) Score
Lasso di tempo: Baseline and Up to approximately 24 months

The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 5 questions about their physical functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Items 1-5 will be presented. Higher scores indicate a better level of functioning.

Baseline and Up to approximately 24 months
Change From Baseline in EORTC QLQ-C30 Role Functioning (Items 6-7) Score
Lasso di tempo: Baseline and Up to approximately 24 months

The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 2 questions about their role functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Items 6-7 will be presented. Higher scores indicate a better level of functioning.

Baseline and Up to approximately 24 months
Change From Baseline in EORTC QLQ-C30 Dyspnea (Item 8) Score
Lasso di tempo: Baseline and Up to approximately 24 months

The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant response to the question "Were you short of breath?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Item 8 will be presented. A higher score indicates a worse level of dyspnea.

Baseline and Up to approximately 24 months
Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Lung Cancer Module (EORTC QLQ-LC13) Cough (Item 31) Score
Lasso di tempo: Baseline and Up to approximately 24 months

The EORTC QLQ-C13 is a lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you coughed?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C13 Item 31 will be presented. A higher score indicates more frequent coughing.

Baseline and Up to approximately 24 months
Change From Baseline in EORTC QLQ-LC13 Chest Pain (Item 40) Score
Lasso di tempo: Baseline and Up to approximately 24 months

The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you had pain in your chest?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C13 Item 40 will be presented. A higher score indicates a worse level of chest pain.

Baseline and Up to approximately 24 months
Time to Deterioration (TTD) in EORTC-QLQ-C30 Global Health Status (Item 29) Quality of Life (Item 30) Combined Score
Lasso di tempo: Baseline and Up to approximately 24 months

TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in global health status (GHS) and quality of life (QoL) (EORTC QLQ-C30 Items 29 and 30) score. Participant responses to the questions "How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?" are scored on a 7-point scale (1= Very poor to 7=Excellent). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in GHS and QoL, will be presented. A longer TTD indicates a better outcome.

Baseline and Up to approximately 24 months
TTD in EORTC-QLQ-C30 Physical Functioning (Items 1-5) Score
Lasso di tempo: Baseline and Up to approximately 24 months

TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in physical functioning (EORTC QLQ-C30 Items 1-5) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 5 questions about their physical functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in physical functioning score, will be presented. A longer TTD indicates a better outcome.

Baseline and Up to approximately 24 months
TTD in EORTC-QLQ-C30 Role Functioning (Items 6-7) Score
Lasso di tempo: Baseline and Up to approximately 24 months

TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in role functioning (EORTC QLQ-C30 Items 6 and 7) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 2 questions about their role functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in role functioning score, will be presented. A longer TTD indicates a better outcome.

Baseline and Up to approximately 24 months
TTD in EORTC-QLQ-C30 Dyspnea (Item 8) Score
Lasso di tempo: Baseline and Up to approximately 24 months

TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in dyspnea (EORTC QLQ-C30 Item 8) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant response to the question "Were you short of breath?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in dyspnea score, will be presented. A longer TTD indicates a better outcome.

Baseline and Up to approximately 24 months
TTD in EORTC QLQ-LC13 Cough (Item 31) Score
Lasso di tempo: Baseline and Up to approximately 24 months

TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in cough (EORTC QLQ-C13 Item 31) score. The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you coughed?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in cough score, will be presented. A longer TTD indicates a better outcome.

Baseline and Up to approximately 24 months
TTD in EORTC QLQ-LC13 Chest Pain (Item 40) Score
Lasso di tempo: Baseline and Up to approximately 24 months

TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in chest pain (EORTC QLQ-C13 Item 40) score. The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you had pain in your chest?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline chest pain score, will be presented. A longer TTD indicates a better outcome.

Baseline and Up to approximately 24 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Direttore dello studio: Medical Director, Merck Sharp & Dohme LLC

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

24 maggio 2024

Completamento primario (Stimato)

24 gennaio 2028

Completamento dello studio (Stimato)

18 febbraio 2031

Date di iscrizione allo studio

Primo inviato

28 marzo 2024

Primo inviato che soddisfa i criteri di controllo qualità

28 marzo 2024

Primo Inserito (Effettivo)

3 aprile 2024

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

12 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

11 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 1084-004
  • MK-1084-004 (Altro identificatore: MSD)
  • U1111-1296-8093 (Identificatore di registro: UTN)
  • jRCT2031240213 (Identificatore di registro: jRCT)
  • PHRR241128-007796 (Identificatore di registro: PHRR)
  • 2023-507776-42-00 (Identificatore di registro: EU CT)
  • KANDLELIT-004 (Altro identificatore: MSD)
  • 2023 (Sovvenzione/contratto NIH degli Stati Uniti)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

https://trialstransparency.msdclinicaltrials.com/pdf/ProcedureAccessClinicalTrialData.pdf

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

Sì

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi